Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 19,912 shares at $90.85 ($1.8M) on 2019-10-14, disclosed to the SEC on 2019-10-16.
Open-market sale of $1.8M NBIX by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.85 | 9,956 | $905K | 50.0% |
| 2 | $90.85 | 9,956 | $905K | 50.0% |
| Total | $90.85 avg | 19,912 | $1.8M | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |